U3Y-25029-06631
1 vaccination
3 coded responses
12 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 231 / VA
- Registered
- 2022-06-25
- Relationship
- Child or adolescent in my care
- Guardian
- 4AB-53733-30323
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Pfizer-BioNTech
-
2022-06-25
Registered in v-safe
-
2022-06-25
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Unevaluable event — Feeling: Good · Site: Pain · Irritability/cryingFree text: ClinginessMedDRA releases: 2024-11 · check-in free text available
-
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-06-29
- 2022-06-30
- 2022-07-09
- 2022-07-16
- 2022-07-21
- 2022-07-28
-
2022-09-22
Survey response — 3 months, dose 1, under 3MedDRA: Body temperature increased, Cough, Nasopharyngitis, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend schoolFree text: What seems to be a minor coldsneezing, runny nose, mild fever (100.1), occasional cough. Have not tested for COVID.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Survey response — 6 months, dose 1, under 3MedDRA: Ear infection, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Several colds (none confirmed COVID), ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Report sent to call center — 6 months, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-23
- 2023-06-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Clinginess
Release 12 (Under 3) — 3 months, dose 1, under 3
Symptoms: What seems to be a minor coldsneezing, runny nose, mild fever (100.1), occasional cough. Have not tested for COVID.
Release 12 (Under 3) — 6 months, dose 1, under 3
Symptoms: Several colds (none confirmed COVID), ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release